Alcoholism is a multifaceted disease with many different etiologies. This probably explains why no single approach to treatment has been universally successful. Clearly, more research is needed. The Medical University of South Carolina (MUSC) is uniquely qualified to fulfill this need, but it requires the resources provided by an Alcohol Research Center (ARC) in order to realize its potential. A Center mechanism permits an institution to embark on a thematic research program by providing an infrastructure which encourages a blending of scientific talents. While clinical research is the most common treatment research approach, advances are more likely to be achieved when clinical research is complemented by animal research. This application for an ARC at MUSC has afforded the opportunity to bring the disciplines of psychiatry and experimental psychology together along the treatment research theme. A total of five research components are proposed, along with four core components that support the research infrastructure, the ARC's education/training mission, or provide support for three pilot projects from young psychiatric researchers. The thread that ties all the research components together is pharmacotherapy. Psychiatric comorbidity represents a secondary area of expertise as well as research interest of some of the faculty. The thematic approach of the proposed ARC is a multidisciplinary one. The projects are interdigitated. Research components #2 and #4 involve medical management of alcohol withdrawal in humans and animals, respectively. Research components 1, #3, and #5 involve evaluation of pharmacologic agents that affect the serotonin and/or opiate systems in humans, or animals, respectively. The approaches and models being employed are applicable to studies of other agents, as well. Thus, the MUSC ARC would be well positioned to evaluate compounds first in animal models, and then in clinical trials. Such an integrated and concerted """"""""bench-to- clinic"""""""" strategy is certainly needed toward achieving the ultimate goal of developing and successfully implementing effective treatment. Further, it is likely that the best therapy will be derived from multidisciplinary and interdisciplinary approaches, and not just from medications alone. Given that matching patients to treatments based on individual psychological or psychiatric characteristics may have more promise than standard homogeneous approaches to improve treatment outcome, it seems like a Center with focused basic and clinical research in this area is sorely needed. MUSC has the dedicated research talent, administrative support, and physical space to be such a Center.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Specialized Center (P50)
Project #
5P50AA010761-03
Application #
2607607
Study Section
Special Emphasis Panel (SRCA (60))
Project Start
1995-12-10
Project End
2000-11-30
Budget Start
1997-12-01
Budget End
1998-11-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Psychiatry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Zamudio-Bulcock, Paula A; Homanics, Gregg E; Woodward, John J (2018) Loss of Ethanol Inhibition of N-Methyl-D-Aspartate Receptor-Mediated Currents and Plasticity of Cerebellar Synapses in Mice Expressing the GluN1(F639A) Subunit. Alcohol Clin Exp Res 42:698-705
Cannady, Reginald; Rinker, Jennifer A; Nimitvilai, Sudarat et al. (2018) Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior. Handb Exp Pharmacol 248:311
Harlan, Benjamin A; Becker, Howard C; Woodward, John J et al. (2018) Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol. Neuropsychopharmacology 43:2064-2074
Hanlon, Colleen A; Dowdle, Logan T; Henderson, J Scott (2018) Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development. Pharmacol Rev 70:661-683
Hanlon, Colleen A; Dowdle, Logan T; Gibson, Nicole B et al. (2018) Cortical substrates of cue-reactivity in multiple substance dependent populations: transdiagnostic relevance of the medial prefrontal cortex. Transl Psychiatry 8:186
Gioia, Dominic A; Xu, Minfu; Wayman, Wesley N et al. (2018) Effects of drugs of abuse on channelrhodopsin-2 function. Neuropharmacology 135:316-327
Anton, Raymond F; Latham, Patricia K; Voronin, Konstantin E et al. (2018) Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcohol Clin Exp Res 42:751-760
Anderson, Ethan M; Larson, Erin B; Guzman, Daniel et al. (2018) Overexpression of the Histone Dimethyltransferase G9a in Nucleus Accumbens Shell Increases Cocaine Self-Administration, Stress-Induced Reinstatement, and Anxiety. J Neurosci 38:803-813
Osterndorff-Kahanek, Elizabeth A; Tiwari, Gayatri R; Lopez, Marcelo F et al. (2018) Long-term ethanol exposure: Temporal pattern of microRNA expression and associated mRNA gene networks in mouse brain. PLoS One 13:e0190841
Stewart, Scott H; Reuben, Adrian; Anton, Raymond F (2018) Reply: Carbohydrate Deficient Transferrin in Patients with Cirrhosis: A Tale of Bridges. Alcohol Alcohol 53:351-352

Showing the most recent 10 out of 209 publications